400
Participants
Start Date
Not specified
Study Completion Date
September 30, 1992
Zalcitabine
Didanosine
Clinical Directors Network of Region II, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York
Bronx Lebanon Hosp Ctr, The Bronx
Wilmington Hosp / Med Ctr of Delaware, Wilmington
Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C.
Richmond AIDS Consortium, Richmond
AIDS Research Consortium of Atlanta, Atlanta
Comprehensive AIDS Alliance of Detroit, Detroit
Henry Ford Hosp, Detroit
AIDS Research Alliance - Chicago, Chicago
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans
Community Consortium of San Francisco, San Francisco
Denver CPCRA / Denver Public Hlth, Denver
Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland
Hill Health Corp, New Haven
North Jersey Community Research Initiative, Newark
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Hoffmann-La Roche
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH